Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit in Dubai
Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7th Edition of Merck Foundation First Ladies Initiative – MFFLI Summit 2025 on 19th and 20th June in Dubai, United Arab Emirates. It was inaugurated by Prof. Dr. Frank Stangenberg-Haverkamp, Chairman of Merck Foundation Board of Trustees, and Senator, Dr. Rasha Kelej, CEO of Merck Foundation and President of Merck Foundation First Ladies Initiative along with The First Ladies of 14 African and Asian countries, who joined as the Guests of Honor and Keynote Speakers.
Senator Dr. Rasha Kelej, CEO of Merck Foundation and President of 'Merck Foundation First Ladies Initiative' emphasized, 'It is my great honor to welcome our esteemed Guests of Honor and Keynote Speakers, The First Ladies of Africa and Asia, and Ambassadors of our 'More Than a Mother' campaign to the 7th Edition of the Merck Foundation First Ladies Initiative – MFFLI Summit.
Through this important platform, we have collectively exchanged valuable experiences and engaged in meaningful discussions on the impact of our programs, which are aimed at transforming patient care and raising awareness of a wide range of critical social and health issues.'
Prof. Dr. Frank Stangenberg Haverkamp, Chairman of Merck Foundation Board of Trustees, added, 'At Merck Foundation, our goal is improving overall health and well-being by building healthcare capacity and by providing access to quality & equitable healthcare solutions in Africa, Asia and beyond. I would like to sincerely thank our Ambassadors and partners. Together, with your unwavering support and collaboration, we will continue to work towards our vision of a world where everyone can lead a healthy and happy life.'
The First Ladies of 14 countries, who are also the Ambassadors of 'Merck Foundation More Than a Mother', joined as Guests of Honor and Keynote Speakers. They are:
Senator, Dr. Rasha Kelej stated, 'I am proud to share that Merck Foundation has provided more than 2280 scholarships for young doctors from 52 countries in 44 critical and underserved specialties. Many of our Merck Foundation Alumni are becoming the first specialists in their countries. Together with our Ambassadors and Partners, we are making history and transforming the patient care landscape across Africa and beyond. Many of them are becoming the first specialists in their countries.'
'During our Conference, we also marked together the World Infertility Awareness Month, observed in June, through our signature campaign 'Merck Foundation More Than a Mother', which aims to empower infertile and childless women by providing access to information, education, and change of mindset. I am happy to share that out of the total 2280 scholarships, more than 700 scholarships have been provided for training in Fertility, Embryology, Sexual and Reproductive Medicine, Clinical Psychiatry, Women's Health, Urology, Laparoscopic Surgical Skills, and Family Medicine, to improve access to fertility care and women's health', she further added.
During the 7th Edition of Merck Foundation First Ladies Initiative -MFFLI Summit, two important occasions were marked: the 8th Anniversary of Merck Foundation and 13 years of Merck Foundation's development programs that started in 2012.
On the first day, the Plenary Session of the Merck Foundation First Ladies Initiative -MFFLI Summit took place, featuring a high-level panel discussion with the participating First Ladies of Africa and Asia. Moreover, a high-level ministerial panel discussion was held with African Ministers and top healthcare experts from across the globe.
On Day 2 of the conference, three key parallel sessions will be held: Two medical and scientific sessions covering Oncology and Fertility Topics, and a community awareness session, Merck Foundation Health Media Training. This session will emphasize the critical role of the media in influencing communities and driving cultural change, with regards to a wide range of social and health issues like Breaking Infertility Stigma, Supporting Girls' Education, Stopping GBV, Ending Child Marriage & FGM, Empowering Women, Diabetes and Hypertension Awareness.
The conference is being conducted in a hybrid format, enabling over 6,000 audiences from more than 70 countries to benefit, meet and discuss strategies and solutions for the health and social challenges in their countries safely and effectively.
Countries participating in the 7th Edition of Merck Foundation First Ladies Initiative:
Angola, Bangladesh, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Canada, Central Africa Republic, Cambodia, Chad, Côte d'Ivoire, Republic of the Congo, Democratic Republic of the Congo, Egypt, Ethiopia, France, Gabon, Germany, Ghana, Guinea – Bissau, Guinea – Conakry, India, Indonesia, Kenya, Lesotho, Liberia, Malawi, Malaysia, Maldives, Mali, Mauritania, Mauritius, Mexico, Mozambique, Myanmar, Namibia, Nepal, Niger, Nigeria, Peru, Philippines, Russia, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Sri Lanka, Sudan, Tanzania, Thailand, The Gambia, Togo, Tunisia, U.A.E, UK, Uganda, US, Vietnam, Zambia, Zimbabwe and more.
The 7th Edition of Merck Foundation First Ladies Initiative is streamed live on the social media handles of Merck Foundation and Senator, Dr. Rasha Kelej, CEO of Merck Foundation:
@Merck Foundation: Facebook, X, Instagram, and YouTube.
@Rasha Kelej: Facebook, X, Instagram, and YouTube.
Link to the Facebook live stream of Inaugural Session of Merck Foundation First Ladies High Level Panel: https://www.facebook.com/share/v/19CGzbGbZM/?mibextid=wwXIfr
Merck Foundation is transforming the Patient care landscape and making history together with their partners in Africa, Asia, and beyond, through:
Merck Foundation is also creating a culture shift and breaking the silence about a wide range of social and health issues in Africa and underserved communities through:
Disclaimer: The above press release comes to you under an arrangement with Business Wire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Business Wire India, established in 2002, India's premier media distribution company ensures guaranteed media coverage through its network of 30+ cities and top news agencies.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
2 hours ago
- Business Insider
Gates Foundation's new world-first contraceptive for African women: what it means for Africa
The Bill & Melinda Gates Foundation is set to launch a new long-acting contraceptive in Africa, beginning with Kenya later this year, as part of a US$2.5 billion commitment to accelerate research and expand services for the health of African women. The Bill & Melinda Gates Foundation is launching a new affordable long-term contraceptive in Africa, starting with Kenya. The contraceptives, including a hormonal IUD effective for up to eight years and a contraceptive patch, aim to address obstacles such as cost and accessibility. While receiving praise, concerns were raised about the ethical implications of externally funded family planning initiatives in Africa. This innovation by the Bill and Melinda Gates foundation follows research showing poor health outcomes for African women, particularly those in underserved communities, and limited R&D funding for women's health conditions beyond cancer. ' Today, women's health issues are still too often misunderstood, misdiagnosed, or ignored. Although women generally live longer than men, they spend 25% more of their lives in poor health. ' Ru-fong Joanne Cheng, Director, Women's Health Innovations, Gates Foundation noted. The new contraceptive: an affordable hormonal intrauterine device (IUD)—is designed to be effective for up to eight years, and will provide a discreet option for women in low-income households. ' A new hormonal IUD designed for affordability and a user-centered experience is being launched in Kenya, Nigeria, and possibly India, ' Dr Anita Zaidi, head of the Gender Equality Division at the Gates Foundation noted. The device is inserted into the uterus, where it releases progestin, a synthetic hormone that thickens cervical mucus to prevent sperm from reaching and fertilising an egg. Ru-fong described the revolutionary contraceptive patch, saying, 'I magine getting six months of contraceptive protection by pressing a small patch onto your skin. Discreet and self-administered.' She further explained that the patch is embedded with microneedles containing progestin, which delivers protection over several months. The foundation emphasized that the new programme will 'ensure that women and girls in low and middle-income countries can access the contraceptives and family planning information they want and thus exercise their right to decide whether to have children and, if so, when and how many.' Dr. Anita also noted that the programme builds on the foundation's 25-year work in maternal and child health, aimed at ending preventable deaths, eliminating deadly infectious diseases, and lifting millions out of poverty by 2045. 'Many women in these communities want to have control over their reproductive health but do not use existing contraceptive methods because of male interference, concerns about side effects, or lack of access to options that meet their specific needs. As a result, nearly half of all pregnancies worldwide—about 45%—are unplanned ' the Foundation said With the help of regional partners and government, the Gates foundation will expand access to the self-injectable contraceptive DMPA-SC to at least 35 countries, including Uganda, Senegal, Malawi, Nigeria, Zambia, and the Democratic Republic of Congo. Other funded innovations include rapid testing for sexually transmitted infections, AI-enabled ultrasound devices, and vaginal health therapies. Why Africa is the Focus According to the Foundation, Sub-Saharan Africa has some of the highest rates of unmet need for family planning globally, with barriers ranging from cost and distance to health facilities to cultural opposition. Many countries also face high rates of adolescent pregnancies, maternal mortality, and limited reproductive health infrastructure. By targeting Africa, the initiative seeks to provide longer-lasting, affordable options in regions where demand for family planning remains largely unmet. As Melinda French Gates emphasized, ' Contraceptives are one of the most powerful tools we have. It puts the power in the hands of young girls and women to plan their families, and quite honestly, to plan their futures.' Potential Implications However, some critics raise concerns that contraceptive programs in Africa may be perceived as externally imposed population control. This notion further suggests that the continent is being used as a testing ground for global health innovations, noting that similar large-scale rollouts are less visible in wealthier nations. Considering concerns from billionaires like Elon Musk and western pro-life activists about declining populations in their own countries, which highlight contrasting demographic priorities, critics argue that the new program not only focuses on population control but also risks taking away one of Africa's major advantages: its growing population.
The Hill
2 days ago
- The Hill
US plans to incinerate $9.7M in USAID contraceptives
The Trump administration plans to incinerate more than $9.7 million worth of U.S. Agency for International Development (USAID)-funded contraceptives that have been lying in a warehouse in Belgium since President Trump's order freezing foreign aid and shutting down USAID. The U.S. government is spending more than $160,000 to burn the mix of birth control pills, shots, implants, and IUDs at a facility in France that destroys medical waste, according to The New York Times. A spokesperson for the Department of State did not immediately respond to questions from The Hill on when the incineration will take place. State in a statement confirmed to the Times that there was a plan to incinerate the products. State also said the products to be incinerated were 'aborifacient,' meaning they induce abortions. But the Times reported that none of the supplies registered for storage in the Belgian warehouse fit that description, and USAID under the law isn't allowed to purchase products that induce abortions. European governments and activist groups have decried the decision. The International Planned Parenthood Federation (IPPF), a nonprofit, estimates incinerating contraceptives will leave 1.4 million women and girls across Africa with access to life-saving care. For the past nine years, USAID has spent $607.5 million on global family planning and reproductive programs, according to the Guttmacher Institute. Those funds have helped operate family planning and reproductive health programs in more than 30 countries. France is currently under pressure to stop the impending destruction of the stockpile from French reproductive rights groups and family planning organizations, although officials said earlier this month they cannot legally seize the contraceptives. IPPF estimates that 77 percent of the supplies are earmarked for five African countries: Kenya, Tanzania, Zambia, Mali, and the Democratic Republic of the Congo (DNC). More than 40 percent of the soon-to-be destroyed supplies were meant for Tanzania alone, according to the nonprofit. IPPF wrote in a statement the supplies are being 'needlessly and egregiously' destroyed and that many of the contraceptives will not expire until 2027 at the earliest and 2029 at the latest. 'This decision to destroy ready-to-use commodities is appalling and extremely wasteful,' said Marie-Evelyne Petrus-Barry, Africa regional director of IPPF. 'These life-saving medical supplies were destined to countries where access to reproductive care is already limited, and in some cases, part of a broader humanitarian response, such as in the DRC.' Destroying the contraceptive supplies will result in 362,000 unintended pregnancies which can force some to seek out unsafe abortions, and will cause 161,000 unplanned births, according to the Reproductive Health Supplies Coalition (RHSC). IPPF estimates that once the contraceptives are destroyed, Tanzania will have more than 1 million fewer injectable contraceptives and 365,100 fewer implants to distribute—or about 28 percent of the country's total annual need. Mali will experience a shortage of more than 1,100,000 oral contraceptives and 95,800 implants or roughly 24 percent of the country's annual need. Zambia will have 48,400 fewer implants and 295,000 injectable contraceptives to distribute to women. In Kenya, nearly 14 percent of the country's annual contraceptive need will not be met, and more than 100,000 women will not be able to access contraceptive implants this year.
Chicago Tribune
3 days ago
- Chicago Tribune
Robert F. Kennedy Jr.'s vow to overhaul vaccine injury program echoes grievances of anti-vaccine movement
WASHINGTON — Health Secretary Robert F. Kennedy Jr. is vowing to 'fix' the federal program for compensating Americans injured by vaccines, opening the door to sweeping changes for a system long targeted by anti-vaccine activists. Health experts and lawyers say updates are needed to help clear a backlog of cases in the Vaccine Injury Compensation Program, created by Congress in 1986 as a no-fault payment system for presumed vaccine injuries. But they also worry Kennedy's changes will reflect his history as a leader in the anti-vaccine movement, which has alternately called for abolishing the program or expanding it to cover unproven injuries and illnesses that aren't connected to vaccines. Kennedy and other critics believe the program is 'too miserly in what it considers to be a vaccine injury,' said Jason Schwartz, a public health expert at Yale University. 'That's created great concern that he could expand what's included.' Anti-vaccine groups have long suggested a link between vaccines and autism, despite scientific consensus that childhood vaccines don't cause the condition. Adding autism to the list of injuries covered by the plan 'would dramatically increase the number of compensable cases, potentially bankrupting it,' Schwartz said. Signed into law under President Ronald Reagan, the compensation program is designed to provide quick, efficient compensation to Americans who report known injuries associated with vaccines, such as rare allergic reactions. At the time of its creation, a number of vaccine-makers were exiting the business due to risks of class action lawsuits. In a recent social media post, Kennedy called the program 'broken' and accused federal lawyers and adjudicators who run it of 'inefficiency, favoritism and outright corruption.' Kennedy didn't specify the changes he's seeking. But some of the people he's enlisted to help have a history of bringing vaccine injury cases. In June, the Department of Health and Human Services awarded a $150,000 contract to an Arizona law firm for 'expertise' in the program. The firm's Andrew Downing, an attorney specializing in vaccine injury cases, was listed in the HHS staff directory for a time. 'We just brought a guy in this week who is going to be revolutionizing the Vaccine Injury Compensation Program,' Kennedy told Tucker Carlson shortly after the award. Revamping the program would be the latest in a string of decisions that have upended U.S. vaccine policy, including this week's cancellation of research funding for vaccines using mRNA technology. Downing has had a leading role in lawsuits against Merck alleging injuries from its HPV vaccine, Gardasil, including a rare movement disorder. In a podcast last year for people with the condition, Downing lamented that the injury compensation program 'has taken a hard line' against such cases, leading lawyers to file injury lawsuits in civil court. Approximately 70% of the Gardasil cases against Merck started as claims filed by Downing in the federal injury program, according to court records. A judge dismissed more than 120 of those cases, citing 'a paucity of evidence' that Gardasil caused patients' problems. A spokesman for Kennedy declined to comment on Downing's hiring. Kennedy himself has been involved in the Gardasil litigation, as both an attorney and consultant. Before joining the government, Kennedy received payments for referring potential Gardasil clients to Wisner Baum, one of the law firms suing Merck. Following questions about the agreement during his confirmation hearings, Kennedy agreed to give up his stake in the deal and transfer any future fees to 'a nondependent, adult son,' according to his financial disclosures. One of Kennedy's sons is an attorney at Wisner Baum. Experts who study vaccine compensation say real changes are needed to modernize the 40-year-old program. The cap on compensation remains $250,000 for injury or death, the same as in 1986. Similarly, the program still has eight adjudicators, known as special masters, to review all cases before the government. On average, the process takes two to three years. The fund has paid out $5.4 billion, compensating about 40% of all people who filed claims. The U.S. has an 'ethical obligation' to promptly pay those harmed by government-recommended vaccines, says Dorit Reiss, a professor at the University of California Hastings College of the Law. 'Plus, I think it increases trust in the vaccination program if you have quick, generous compensation,' Reiss said. As health secretary, Kennedy has broad powers to reshape the program. One approach could be adding new diseases and illnesses to the government table of payable injuries. In the early 2000s, the program ruled against more than 5,000 claims from families who said vaccines led to their children's autism, citing hundreds of scientific studies discrediting the link. Critics of Kennedy say he could claim that he has new evidence of harm — perhaps from a large autism study he's commissioned — and add the condition to the program. In response, the federal government might have to increase taxes on vaccines to replenish the compensation fund, which would make the shots more expensive and less accessible. 'Then you will start to watch the vaccine program infrastructure in this country disintegrate until someone steps in,' Dr. Paul Offit, a vaccine researcher at Children's Hospital of Philadelphia who has clashed with Kennedy for years. A recent Senate hearing titled 'Voice of the Vaccine Injured' appeared to make the case for expanding the program. Witnesses included two representatives from Children's Health Defense, the nonprofit group that Kennedy previously chaired and has repeatedly sued the government over vaccines. The group's chief science officer, Brian Hooker, told lawmakers he tried unsuccessfully for 16 years trying to get compensation for his son's autism, which he attributes to the measles-mumps-rubella vaccine. Another approach would involve removing certain vaccines from the program, making it easier to bring lawsuits against vaccine-makers. Under current law, people claiming injuries from vaccines covered by the program must first pursue a compensation claim before they can sue. In cases where the science doesn't support a connection to vaccines, lawyers might be more successful before a jury. 'Jury trials take advantage of the fact that most jurors don't know anything about science or medicine,' Offit said. 'They are not going to be as easily moved by the data.' Still, attorneys who bring cases before the compensation program say the process has become more burdensome and adversarial over the years. Even small changes could improve things. For instance, the statute of limitations for claims could be extended beyond the current three years, which lawyers say cuts off many potential clients. 'I'm hoping there will be changes put in place that make the program easier for petitioners to navigate' said Leah Durant, a vaccine injury attorney.
